Publication | Open Access

The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma

Hematological MalignancyCar-hematotox ScoreMedicineMalignant Blood DisorderImmunologyHematologyPathologyRelapsed/refractory Multiple MyelomaBcma-directed Car-tImmunotherapyOncologyTumor Microenvironment